Prostaglandin D2 induces interleukin-6 synthesis via Ca2+ mobilization in osteoblasts: regulation by protein kinase C

Prostaglandins Leukot Essent Fatty Acids. 1999 Sep;61(3):189-94. doi: 10.1054/plef.1999.0089.

Abstract

We previously showed that prostaglandin (PG) D2 stimulates Ca2+ influx from extracellular space and activates phosphoinositidic (PI)-hydrolyzing phospholipase C and phosphatidylcholine (PC)-hydrolyzing phospholipase D independently from PGE2 or PGF2alpha in osteoblast-like MC3T3-E1 cells. In the present study, we investigated the effect of PGD2 on the synthesis of interleukin-6 (IL-6) and its regulatory mechanism in MC3T3-E1 cells. PGD2 significantly stimulated IL-6 synthesis dose-dependently in the range between 10 nM and 10 microM. The depletion of extracellular Ca2+ by EGTA reduced the PGD2-induced IL-6 synthesis. TMB-8, an inhibitor of intracellular Ca2+ mobilization, significantly inhibited the PGD2-induced IL-6 synthesis. On the other hand, calphostin C, a specific inhibitor of protein kinase C (PKC), enhanced the synthesis of IL-6 induced by PGD2. In addition, U-73122, an inhibitor of phospholipase C, and propranolol, a phosphatidic acid phosphohydrolase inhibitor, enhanced the PGD2-induced IL-6 synthesis. These results strongly suggest that PGD2 stimulates IL-6 synthesis through intracellular Ca2+ mobilization in osteoblasts, and that the PKC activation by PGD2 itself regulates the over-synthesis of IL-6.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Animals, Newborn
  • Calcium / metabolism*
  • Calcium Channel Blockers / pharmacology
  • Clone Cells
  • Enzyme Inhibitors / pharmacology
  • Estrenes / pharmacology
  • Gallic Acid / analogs & derivatives
  • Gallic Acid / pharmacology
  • Interleukin-6 / biosynthesis*
  • Mice
  • Naphthalenes / pharmacology
  • Osteoblasts / drug effects
  • Osteoblasts / metabolism*
  • Phosphodiesterase Inhibitors / pharmacology
  • Propranolol / pharmacology
  • Prostaglandin D2 / pharmacology*
  • Protein Kinase C / antagonists & inhibitors
  • Protein Kinase C / metabolism*
  • Pyrrolidinones / pharmacology

Substances

  • Calcium Channel Blockers
  • Enzyme Inhibitors
  • Estrenes
  • Interleukin-6
  • Naphthalenes
  • Phosphodiesterase Inhibitors
  • Pyrrolidinones
  • 1-(6-((3-methoxyestra-1,3,5(10)-trien-17-yl)amino)hexyl)-1H-pyrrole-2,5-dione
  • 8-(N,N-diethylamino)octyl-3,4,5-trimethoxybenzoate
  • Gallic Acid
  • Propranolol
  • Protein Kinase C
  • calphostin C
  • Prostaglandin D2
  • Calcium